Title | Type | SJR | H index | Total Docs. (2013) | Total Docs. (3years) | Total Refs. (2013) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2013) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Vascular Pharmacology | journal | 1.368 Q1 | 108 | 69 | 178 | 4339 | 776 | 165 | 4.88 | 62.88 | |
2 | Value in Health Regional Issues | journal | 0.143 Q3 | 28 | 63 | 43 | 1739 | 26 | 39 | 0.60 | 27.60 | |
3 | U.S. Pharmacist | trade journal | 0.113 Q4 | 12 | 141 | 462 | 2343 | 33 | 393 | 0.05 | 16.62 | |
4 | Trends in Medical Research (discontinued) | journal | 0.123 Q4 | 11 | 6 | 25 | 192 | 8 | 25 | 0.35 | 32.00 | |
5 | Toxicology and Applied Pharmacology | journal | 1.431 Q1 | 189 | 375 | 904 | 19610 | 4107 | 887 | 4.08 | 52.29 | |
6 | Toxicologic Pathology | journal | 0.894 Q2 | 124 | 100 | 352 | 4974 | 1193 | 328 | 2.75 | 49.74 | |
7 | Topics in antiviral medicine | journal | 2.000 Q1 | 46 | 15 | 63 | 361 | 314 | 61 | 4.98 | 24.07 | |
8 | Therapeutic Innovation and Regulatory Science | journal | 0.100 Q4 | 51 | 177 | 366 | 2045 | 144 | 330 | 0.42 | 11.55 | |
9 | Therapeutic Drug Monitoring | journal | 0.677 Q2 | 102 | 114 | 363 | 3933 | 796 | 326 | 2.00 | 34.50 | |
10 | Strategies and Tactics in Organic Synthesis | book series | 0.162 Q4 | 10 | 13 | 17 | 891 | 3 | 0 | 0.18 | 68.54 | |
11 | Steroids | journal | 0.984 Q2 | 114 | 179 | 567 | 7163 | 1775 | 558 | 3.01 | 40.02 | |
12 | Research Journal of Environmental Toxicology (discontinued) | journal | 0.162 Q4 | 19 | 5 | 93 | 133 | 61 | 93 | 0.83 | 26.60 | |
13 | Research in Social and Administrative Pharmacy | journal | 0.440 Q2 | 69 | 94 | 138 | 3520 | 185 | 120 | 1.34 | 37.45 | |
14 | Reproductive Toxicology | journal | 1.036 Q2 | 129 | 122 | 433 | 6274 | 1381 | 398 | 3.05 | 51.43 | |
15 | Report on carcinogens. Monograph on .. | book series | 2 | 2 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | ||
16 | Regulatory Toxicology and Pharmacology | journal | 0.830 Q2 | 123 | 139 | 460 | 6150 | 1271 | 434 | 2.53 | 44.24 | |
17 | Reading Teacher | journal | 0.563 Q3 | 60 | 78 | 254 | 1504 | 255 | 225 | 0.95 | 19.28 | |
18 | Psychopharm Review | trade journal | 0.157 Q4 | 5 | 12 | 36 | 483 | 16 | 36 | 0.38 | 40.25 | |
19 | Prostaglandins and Other Lipid Mediators | journal | 1.082 Q1 | 86 | 57 | 148 | 3661 | 445 | 144 | 3.12 | 64.23 | |
20 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | journal | 1.752 Q1 | 150 | 240 | 783 | 16667 | 3083 | 648 | 4.37 | 69.45 | |
21 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.199 Q3 | 29 | 12 | 34 | 1144 | 19 | 0 | 0.58 | 95.33 | |
22 | Proceedings of the Western Pharmacology Society | journal | 0.157 Q4 | 25 | 0 | 36 | 0 | 22 | 36 | 0.87 | 0.00 | |
23 | PPAR Research | journal | 0.900 Q2 | 59 | 34 | 164 | 2093 | 392 | 157 | 1.75 | 61.56 | |
24 | PLoS Neglected Tropical Diseases | journal | 2.537 Q1 | 163 | 621 | 1316 | 28943 | 7042 | 1286 | 4.97 | 46.61 | |
25 | Pharmacy Times | trade journal | 0.102 Q4 | 8 | 334 | 703 | 1608 | 13 | 414 | 0.02 | 4.81 | |
26 | Pharmacopeial Forum (discontinued) | journal | 0.137 Q4 | 20 | 27 | 53 | 276 | 17 | 32 | 0.14 | 10.22 | |
27 | Pharmacology Biochemistry and Behavior | journal | 1.281 Q1 | 148 | 244 | 767 | 13530 | 2402 | 764 | 3.18 | 55.45 | |
28 | Pharmacology and Therapeutics | journal | 3.622 Q1 | 233 | 105 | 312 | 21154 | 3026 | 311 | 9.21 | 201.47 | |
29 | Pharmacological Reviews | journal | 12.114 Q1 | 254 | 36 | 91 | 13930 | 2347 | 91 | 20.90 | 386.94 | |
30 | Pharmacological Research | journal | 1.702 Q1 | 169 | 128 | 433 | 9193 | 2275 | 421 | 4.58 | 71.82 | |
31 | Pharmacogenetics and Genomics | journal | 1.317 | 152 | 92 | 306 | 3658 | 1320 | 303 | 4.05 | 39.76 | |
32 | Pharmaceutical Technology Europe | journal | 0.107 Q4 | 19 | 75 | 319 | 305 | 22 | 238 | 0.06 | 4.07 | |
33 | Pharmaceutical Technology | journal | 0.248 Q2 | 42 | 157 | 630 | 612 | 94 | 544 | 0.15 | 3.90 | |
34 | Pharmaceutical Research | journal | 1.570 Q1 | 229 | 263 | 806 | 11253 | 4175 | 768 | 4.69 | 42.79 | |
35 | Pharmaceutical Processing | trade journal | 0.104 Q4 | 4 | 57 | 210 | 96 | 4 | 91 | 0.03 | 1.68 | |
36 | Pharmaceutical Outsourcing | journal | 0.115 Q4 | 7 | 42 | 112 | 388 | 11 | 97 | 0.13 | 9.24 | |
37 | Pharmaceutical Formulation and Quality | trade journal | 0.100 Q4 | 1 | 0 | 130 | 0 | 0 | 124 | 0.00 | 0.00 | |
38 | Pharmaceutical Engineering | journal | 0.154 Q3 | 18 | 54 | 160 | 419 | 22 | 143 | 0.13 | 7.76 | |
39 | Pharmaceutical Development and Technology | journal | 0.452 Q2 | 70 | 158 | 232 | 4510 | 330 | 228 | 1.41 | 28.54 | |
40 | Pharmaceutical Chemistry Journal | journal | 0.161 Q4 | 39 | 139 | 453 | 2612 | 141 | 409 | 0.27 | 18.79 | |
41 | PDA Journal of Pharmaceutical Science and Technology | journal | 0.422 Q2 | 43 | 55 | 211 | 1313 | 160 | 178 | 0.78 | 23.87 | |
42 | Pain | journal | 2.987 Q1 | 296 | 406 | 1195 | 19086 | 6832 | 893 | 5.30 | 47.01 | |
43 | Nucleic Acid Therapeutics | journal | 1.046 Q1 | 77 | 54 | 137 | 1684 | 453 | 131 | 3.51 | 31.19 | |
44 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 9 | 4 | 28 | 749 | 0 | 28 | 0.00 | 187.25 | ||
45 | NTP monograph | journal | 0.122 | 2 | 0 | 1 | 0 | 0 | 1 | 0.00 | 0.00 | |
46 | Neurotoxicology and Teratology | journal | 1.043 Q2 | 111 | 64 | 232 | 4497 | 747 | 221 | 3.26 | 70.27 | |
47 | Neurotoxicity Research | journal | 1.440 Q1 | 84 | 76 | 234 | 5905 | 879 | 233 | 3.56 | 77.70 | |
48 | Neuropsychopharmacology Reports | journal | 22 | 1 | 14 | 0 | 0 | 10 | 0.00 | 0.00 | ||
49 | Neuromethods | book series | 0.234 Q2 | 24 | 145 | 493 | 9977 | 168 | 427 | 0.35 | 68.81 | |
50 | Natural Product Communications | journal | 0.412 Q3 | 63 | 457 | 1294 | 11133 | 1501 | 1268 | 1.10 | 24.36 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®